Design, synthesis and characterization of novel 1,3,4-oxadiazole dimers from benzoic acids

International Journal of ChemTech Research

Volumn 2, Issue 4, 2010, Pages 2055-2062

  Joyashis, Bhattacharya ^a   Kuldeep, Patel ^a   Prafull, Tailor ^a   Karthikeyan, C ^a   Moorthy, N S H N ^b   Piyush, Trivedi ^a  

^a Rajiv Gandhi Proudyogiki Vishwavidyalaya   (India)

^b UNIVERSITY OF PORTO   (Portugal)

Author keywords

1,3,4 oxadiazole; Benzoic acids; Dimers; Monomers

Indexed keywords

1,3 BIS 4 [5 (4 METHOXYPHENYL)[1,3,4]OXADIAZOL 2 YL]PHENYLUREA; 1,3,4 OXADIAZOLE DERIVATIVE; 1,4 BIS[5 (3,5 DIMETHOXYPHENYL)[1,3,4]OXADIAZOL 2 YL]BENZENE; BENZOIC ACID; BIS 4 [5 (4 METHOXYPHENYL)[1,3,4]OXADIAZOL 2 YL]PHENYLETHER; BIS [4 [5 (3,5 DIMETHOXYPHENYL)[1,3,4]OXADIAZOL 2 YL]PHENYL]AMINO ETHANE; BIS [4 [5 (3,5 DIMETHOXYPHENYL)[1,3,4]OXADIAZOL 2 YL]PHENYL]AMINO METHANE; BIS [5 (4 METHOXYPHENYL) 1,3,4 OXADIAZOL 2 YL]METHANE; ESTER; HYDRAZIDE; PHOSPHORUS DERIVATIVE; UNCLASSIFIED DRUG;

AQUEOUS SOLUTION; ARTICLE; CYCLIZATION; DRUG DESIGN; DRUG STRUCTURE; DRUG SYNTHESIS; NUCLEOPHILICITY; OXIDATION;

EID: 78249274216     PISSN: None     EISSN: 09744290     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Christoffersen, R. E.; Marr, J. J. The Management of Drug Discovery: Principles and Practice. In Burger's Medicinal Chemistry and Drug Discovery, 5th ed.; Chang, Y. L.; Klug, L. M.; Wolff, M. E.; Eds., Vol. 1, John Wiley and Sons, Inc., New York, USA, 1995, pp 10-20.
2. Mitscher, L. A. Drug Design and Discovery: An Overview. In Text Book of Drug Design and Discovery, 3rd ed.; Larsen, K. P.; Liljefors, T.; Madsen, U., Eds., Taylor and Francis, London, 2002, pp 1-33.
3. Patrick, L. G., In.; An introduction to medicinal chemistry, 2nd ed.; In., Oxford University Press Inc., New York, 2001, pp 153-167.
4. Tanaka, K.; Toda, F.; Solvent free organic synthesis, Chem. Rev., 2000, 100, 1025-1074.
5. Chandrasekhar, S.; Narshimulu, C.; Sultana, S. S.; Saritha, B.; Prakash, S. J.; Solvent and catalyst free three component coupling of carbonyl compounds, amines and triethylphophite, a new synthesis of a-amino phosphonates, Synlett, 2003, 505-507.
6. http://en.wikipedia.org/wiki/onepot_synthesis.
7. Joule, J. A.; Mills, K., In.; Heterocyclic Chemistry, 4th ed.; Blackwell Publishing, Oxford, USA, 2000, pp 511-515.
8. Mitchell, M. A.; Kelly, R. C.; Wichienski, M. A.; Hatzenbuhler, N. T.; Williams, M. G.; Petzold, G.L.; Slington, J. L.; Siemieniak, D. R. Synthesis and DNA cross linking by a rigid CPI dimer, J. Am. Chem. Soc., 1991, 113, 8994-8999.
9. Bose, S. D.; Thompson, S. A.; Hartley, J. A.; Berardinin, M. D.; Jenkins, T. C.; Neidle, S.; Hurley, L. H.; Thurston, D. E. Rational design of a highly effective irreversible interstrand cross-linking agent based on the pyrrolo benzodiazepine ring system, J. Am. Chem. Soc., 1992, 114, 4939-4941.
10. Seth, P. P., Jefferson, E.A., Risen, L.M., Osgold, S. A., Identification of 2- aminobenzimidazole dimers as antibacterial agents, Bioorg. Med. Chem. Lett., 2003, 13, 1669-1672.
11. Dubey, R. Microwave assisted synthesis, its validation and biological evaluations of potent anti tumor benzothiazole derivatives and their dimers, A major project report of M. Pharm Thesis, SOPS, RGPV, Bhopal, 2005, 38-45.
12. Kamal, A.; Reddy, P. S. M. M.; Reddy, R. The effect of C-2 fluoro group on the biological activity of DC-81 and its dimers, Bioorg. Med. Chem. Lett., 2004, 14, 2669-2672.
13. DNA cross linking agents in molecular aspects of anti cancer drug action, Kohn, K. W.; Nedidle, S.; Wasing, M. J.; Eds.; Macmillan Press, London, 1983, pp 315-361.
14. www.scripps.edu/chem/wong/optimer.html
15. Rang, H. P.; Dale, M. M.; Ritter, J. M., Pharmacology, 4th Ed., Churchill Livingstone, London, 1999, pp 663-670.
16. Calabresi, P.; Chamber, B. A. Chemotherapy of Neoplastic Diseases. In The Pharmacological Basis of Therapeutics, 10th Ed.; Gilman, A. G.; Goodman, L. S.; Rall, T. W.; Murad, F.; Eds.; McGraw Hill, New Delhi, 2004, pp 1381-1459.
17. Tripathi, K. D., In.; Essentials of Medical Pharmacology, 3rd Ed.; Jaypee Brothers, New Delhi, 1994, pp 756-757.
18. Wakelin, L. P. G.; Waring, M. J. In Comprehensive medicinal Chemistry: The Rational Design, Mechanistic Study and Therapeutic Application of Chemical Compounds, Vol. 2, Enzymes and other Molecular Targets, Hansch,; Sammes,; Taylor,; Ed.; Pergamon Press, Oxford, England, 2005, pp- 703-724.
19. www.DermNetNZ.com
20. Martin, A. R. Anti-infective Agents. In Wilson and Gisvold's Textbook of Organic Medicinal and Pharmaceutical Chemistry, 10th ed.; Delgado, J. N.; Remers, W.A.; Eds., Lippincott Williams and Wilkins, Philadelphia, USA, 1998, pp- 185-196.
21. Griffith, R.; Tracy, T. Antifungal Drugs. In Foye's Principles of Medicinal Chemistry, 5th ed.; Williams, D. A.; Lemke, T. L.; Eds., Lippincott Williams and Wilkins, Philadelphia, USA, 2002, pp- 891-901.
22. Gaonkar, S. L.; Rai, K. M. L.; Prabhuswamy, B. Synthesis and antimicrobial studies of a new series of 2-{4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl}-5-substituted-1,3,4-oxadiazoles, Eu. J. Med. Chem., 2006, 41, 841-846.
23. Mikroyannidis, J. A., Spiliopoulos, L. K., Kasimis, T. S., Kulkarni, A. P. Jenekhe, S. A. Synthesis, Photophysics, and Electroluminescence of Conjugated Poly(pphenylenevinylene) Derivatives with 1,3,4-Oxadiazoles in the Backbone, Macromolecules, 2003, 36, 9295-9302.
24. Joo, H. K.; Joo, H. P.; Hoosung, L. Highly Efficient Novel Poly(p-phenylenevinylene) Derivative with 1,3,4-oxadiazole Pendant on a Vinylene Unit, Chem. Mater., 2003, 15, 3414-3416.
25. Lee, D. W.; Kwon, K. Y.; Jin, J.; Park, Y.; Kim, Y. R.; Hwang, I. W. Luminescence Properties of Structurally Modified PPVs: PPV Derivatives Bearing 2-(4-tert- Butylphenyl)-5-phenyl-l,3,4-oxadiazole Pendants, Chem. Mater., 2001, 13, 565-574.
26. Kang, S.; Saito, Y.; Watanabe, N.; Tokita, M.; Takanishi, Y.; Takezoe, H.; Watanabe, J. Low-Birefringent, Chiral Banana Phase below Calamitic Nematic and/or Smectic C Phases in Oxadiazole Derivatives, J. Phys. Chem. B, 2006, 110, 5205-5214.
27. Chen, S. H.; Chen, Y. Poly (p phenylenevinylene) Derivatives Containing Electron-Transporting Aromatic Triazole or Oxadiazole Segments, Macromolecules, 2005, 38, 53-60.
28. Wang, C.; Palsson, L. O.; Batsanov, A. S.; Bryce, M. R. Molecular Wires Comprising Extended Ethynyl- and Butadiynyl-2,5- Diphenyl-1,3,4-Oxadiazole Derivatives: Synthesis, Redox, Structural, and Optoelectronic Properties, JACS articles, 2006.
29. Ouyang, X.; Piatnitski, E. L.; Pattaropong, V.; Chen, X.; He, H.Y.; Kiselyov, A. S.; Velankar, A.; Kawakami, J.; Labelle, M.; Smith, L. II.; Lohman, J.; Lee, S. P.; Malikzay, A.; Fleming, J.; Gerlak, J.; Wang, Y.; Rosler, R. L.; Zhou, K.; Mitelman, S.; Camara, M.; Surguladze, D.; Doody, J. F.; Tuma, M. C. Oxadiazole derivatives as a novel class of antimitotic agents: Synthesis, inhibition of tubulin polymerization, and activity in tumor cell lines, Bioorg. & Med. Chem. Lett., 2006, 16, 1191-1196.